Basak O, Beumer J, Wiebrands K, Seno H, van Oudenaarden A, Clevers H
Annals of Internal Medicine DOI:10.7326/ANNALS-25-00860 Abstract Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy: A Target Trial Emulation Background: There are few data evaluating the association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and nonarteritic anterior ischemic optic neuropathy (NAION), which constitutes approximately 75% of ischemic optic neuropathy (ION) cases in adults
Its endogenous form has a plasma half-life of only 2-3 minutes due to rapid degradation by dipeptidyl peptidase-4 (DPP-4) and renal clearance
To view a copy of this licence, visit About this article Cite this article Han, S., Dong, D
Duman RS, Aghajanian GK, Sanacora G, Krystal JH (2016) Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Because of their molecular structure (long carbon chains), a key issue when handling lipids is the excessive numbers of possible annotated metabolites associated with one m / z mass (Supplementary Table 3)